blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3463559

EP3463559 - CUSTOMIZED PRIMING BY NEUROMODULATION DEVICE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.02.2021
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  13.03.2020
FormerGrant of patent is intended
Status updated on  29.10.2019
FormerRequest for examination was made
Status updated on  08.03.2019
FormerThe international publication has been made
Status updated on  08.12.2017
Formerunknown
Status updated on  22.06.2017
Most recent event   Tooltip15.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 17.08.2022  [2022/33]
Applicant(s)For all designated states
Boston Scientific Neuromodulation Corporation
25155 Rye Canyon Loop
Valencia, CA 91355 / US
[2019/15]
Inventor(s)01 / DOAN, Que T.
23844 Strathern Street
West Hills, CA 91304 / US
02 / HERSHEY, Bradley Lawrence
25532 Via Heraldo
Valencia, CA 91355 / US
03 / ZHU, Changfang
27941 Mariposa Street
Valencia, CA 91355 / US
 [2019/48]
Former [2019/15]01 / DOAN, Que T.
23844 Strathern Street
West Hills California 91304 / US
02 / HERSHEY, Bradley Lawrence
25532 Via Heraldo
Valencia California 91355 / US
03 / ZHU, Changfang
27941 Mariposa Street
Valencia California 91355 / US
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2019/15]
Application number, filing date17729693.601.06.2017
[2019/15]
WO2017US35401
Priority number, dateUS201662344905P02.06.2016         Original published format: US 201662344905 P
[2019/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017210401
Date:07.12.2017
Language:EN
[2017/49]
Type: A1 Application with search report 
No.:EP3463559
Date:10.04.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 07.12.2017 takes the place of the publication of the European patent application.
[2019/15]
Type: B1 Patent specification 
No.:EP3463559
Date:15.04.2020
Language:EN
[2020/16]
Search report(s)International search report - published on:EP07.12.2017
ClassificationIPC:A61N1/36
[2019/15]
CPC:
A61N1/36057 (EP,US); A61N1/37241 (US); A61N1/36071 (EP,US);
A61N1/36125 (US); A61N1/36139 (EP,US); A61N1/36164 (EP,US);
A61N1/0551 (EP,US); A61N2001/083 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/15]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ANGEPASSTES PRIMING DURCH NEUROMODULATIONSVORRICHTUNG[2019/15]
English:CUSTOMIZED PRIMING BY NEUROMODULATION DEVICE[2019/15]
French:AMORÇAGE PERSONNALISÉ PAR UN DISPOSITIF DE NEUROMODULATION[2019/15]
Entry into regional phase02.01.2019National basic fee paid 
02.01.2019Designation fee(s) paid 
02.01.2019Examination fee paid 
Examination procedure02.01.2019Examination requested  [2019/15]
02.01.2019Date on which the examining division has become responsible
07.08.2019Amendment by applicant (claims and/or description)
30.10.2019Communication of intention to grant the patent
06.03.2020Fee for grant paid
06.03.2020Fee for publishing/printing paid
06.03.2020Receipt of the translation of the claim(s)
Opposition(s)18.01.2021No opposition filed within time limit [2021/12]
Fees paidRenewal fee
13.06.2019Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.06.2017
AL15.04.2020
AT15.04.2020
CY15.04.2020
CZ15.04.2020
DK15.04.2020
EE15.04.2020
ES15.04.2020
FI15.04.2020
HR15.04.2020
IT15.04.2020
LT15.04.2020
LV15.04.2020
MC15.04.2020
MK15.04.2020
MT15.04.2020
NL15.04.2020
PL15.04.2020
RO15.04.2020
RS15.04.2020
SE15.04.2020
SI15.04.2020
SK15.04.2020
SM15.04.2020
TR15.04.2020
LU01.06.2020
FR15.06.2020
BE30.06.2020
CH30.06.2020
LI30.06.2020
BG15.07.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
[2022/33]
Former [2022/27]HU01.06.2017
AL15.04.2020
AT15.04.2020
CY15.04.2020
CZ15.04.2020
DK15.04.2020
EE15.04.2020
ES15.04.2020
FI15.04.2020
HR15.04.2020
IT15.04.2020
LT15.04.2020
LV15.04.2020
MC15.04.2020
MT15.04.2020
NL15.04.2020
PL15.04.2020
RO15.04.2020
RS15.04.2020
SE15.04.2020
SI15.04.2020
SK15.04.2020
SM15.04.2020
TR15.04.2020
LU01.06.2020
FR15.06.2020
BE30.06.2020
CH30.06.2020
LI30.06.2020
BG15.07.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2021/23]AL15.04.2020
AT15.04.2020
CZ15.04.2020
DK15.04.2020
EE15.04.2020
ES15.04.2020
FI15.04.2020
HR15.04.2020
IT15.04.2020
LT15.04.2020
LV15.04.2020
MC15.04.2020
NL15.04.2020
PL15.04.2020
RO15.04.2020
RS15.04.2020
SE15.04.2020
SI15.04.2020
SK15.04.2020
SM15.04.2020
LU01.06.2020
FR15.06.2020
BE30.06.2020
CH30.06.2020
LI30.06.2020
BG15.07.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2021/20]AL15.04.2020
AT15.04.2020
CZ15.04.2020
DK15.04.2020
EE15.04.2020
ES15.04.2020
FI15.04.2020
HR15.04.2020
IT15.04.2020
LT15.04.2020
LV15.04.2020
MC15.04.2020
NL15.04.2020
PL15.04.2020
RO15.04.2020
RS15.04.2020
SE15.04.2020
SK15.04.2020
SM15.04.2020
LU01.06.2020
CH30.06.2020
LI30.06.2020
BG15.07.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2021/15]AL15.04.2020
AT15.04.2020
CZ15.04.2020
DK15.04.2020
EE15.04.2020
ES15.04.2020
FI15.04.2020
HR15.04.2020
IT15.04.2020
LT15.04.2020
LV15.04.2020
MC15.04.2020
NL15.04.2020
PL15.04.2020
RO15.04.2020
RS15.04.2020
SE15.04.2020
SK15.04.2020
SM15.04.2020
LU01.06.2020
BG15.07.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2021/10]AL15.04.2020
AT15.04.2020
CZ15.04.2020
DK15.04.2020
EE15.04.2020
ES15.04.2020
FI15.04.2020
HR15.04.2020
IT15.04.2020
LT15.04.2020
LV15.04.2020
MC15.04.2020
NL15.04.2020
PL15.04.2020
RO15.04.2020
RS15.04.2020
SE15.04.2020
SK15.04.2020
SM15.04.2020
BG15.07.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2021/09]AL15.04.2020
AT15.04.2020
CZ15.04.2020
DK15.04.2020
EE15.04.2020
ES15.04.2020
FI15.04.2020
HR15.04.2020
IT15.04.2020
LT15.04.2020
LV15.04.2020
MC15.04.2020
NL15.04.2020
RO15.04.2020
RS15.04.2020
SE15.04.2020
SM15.04.2020
BG15.07.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2021/08]AL15.04.2020
DK15.04.2020
ES15.04.2020
FI15.04.2020
HR15.04.2020
LT15.04.2020
LV15.04.2020
NL15.04.2020
RO15.04.2020
RS15.04.2020
SE15.04.2020
SM15.04.2020
BG15.07.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2021/04]AL15.04.2020
FI15.04.2020
HR15.04.2020
LT15.04.2020
LV15.04.2020
NL15.04.2020
RS15.04.2020
SE15.04.2020
BG15.07.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2021/01]FI15.04.2020
HR15.04.2020
LT15.04.2020
LV15.04.2020
NL15.04.2020
RS15.04.2020
SE15.04.2020
BG15.07.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2020/51]FI15.04.2020
HR15.04.2020
LT15.04.2020
LV15.04.2020
NL15.04.2020
RS15.04.2020
SE15.04.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2020/50]FI15.04.2020
HR15.04.2020
LT15.04.2020
LV15.04.2020
NL15.04.2020
SE15.04.2020
NO15.07.2020
GR16.07.2020
IS15.08.2020
PT17.08.2020
Former [2020/48]FI15.04.2020
LT15.04.2020
NL15.04.2020
SE15.04.2020
NO15.07.2020
IS15.08.2020
PT17.08.2020
Former [2020/47]LT15.04.2020
NO15.07.2020
IS15.08.2020
Former [2020/46]IS15.08.2020
Cited inInternational search[A]WO9639932  (UROMED CORP [US], et al) [A] 1-9* pages 20-22 *;
 [XI]US2014277267  (VANSICKLE DENNIS ALLEN [US], et al) [X] 1-6 * paragraphs [0061] - [0080] - [0114] , [0144] - [0147]; figures 1-2,18 * [I] 7-9;
 [XP]WO2016154091  (VALLEJO RICARDO [US], et al) [XP] 1-9 * pages 23-25 *;
 [XP]WO2016176425  (BOSTON SCIENT NEUROMODULATION CORP [US], et al) [XP] 1-9 * paragraphs [0070] - [0073] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.